News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Swings To Profit On Bausch & Lomb Buy



2/27/2014 7:44:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valeant Pharmaceuticals International Inc , Canada's largest listed drugmaker, swung to a quarterly profit driven by the acquisition of contact lens maker Bausch & Lomb Holdings Inc. Valeant's net income attributable to the company was $123.8 million, or 36 cents per share, for the fourth quarter ended Dec. 31. The company reported a loss of $89.1 million, or 29 cents per share, a year earlier.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES